Coevolution of synchronous activity and connectivity in coupled chaotic oscillators

We investigate the coevolution dynamics of node activities and coupling strengths in coupled chaotic oscillators via a simple threshold adaptive scheme. The coupling strength is synchronous activity regulated, which in turn is able to boost the synchronization remarkably. In the case of weak coupling, the globally coupled oscillators present a highly clustered functional connectivity with a power-law distribution in the tail with γ≃3.1, while for strong coupling, they self-organize into a network with a heterogeneously rich connectivity at the onset of synchronization but exhibit rather sparse structure to maintain the synchronization in noisy environment. The relevance of the results is briefly discussed

AdaLomo: Low-memory Optimization with Adaptive Learning Rate

Large language models have achieved remarkable success, but their extensive parameter size necessitates substantial memory for training, thereby setting a high threshold. While the recently proposed low-memory optimization (LOMO) reduces memory footprint, its optimization technique, akin to stochastic gradient descent, is sensitive to hyper-parameters and exhibits suboptimal convergence, failing to match the performance of the prevailing optimizer for large language models, AdamW. Through empirical analysis of the Adam optimizer, we found that, compared to momentum, the adaptive learning rate is more critical for bridging the gap. Building on this insight, we introduce the low-memory optimization with adaptive learning rate (AdaLomo), which offers an adaptive learning rate for each parameter. To maintain memory efficiency, we employ non-negative matrix factorization for the second-order moment estimation in the optimizer state. Additionally, we suggest the use of a grouped update normalization to stabilize convergence. Our experiments with instruction-tuning and further pre-training demonstrate that AdaLomo achieves results on par with AdamW, while significantly reducing memory requirements, thereby lowering the hardware barrier to training large language models.Comment: Fix some typ

Calibration of metallicity of LAMOST M dwarf stars Using FGK+M wide binaries

Estimating precise metallicity of M dwarfs is a well-known difficult problem due to their complex spectra. In this work, we empirically calibrate the metallicity using wide binaries with a F, G, or K dwarf and a M dwarf companion. With 1308 FGK+M wide binaries well observed by LAMOST, we calibrated M dwarf's [Fe/H] by using the Stellar LAbel Machine (SLAM) model, a data-driven method based on support vector regression (SVR). The [Fe/H] labels of the training data are from FGK companions in range of [-1,0.5] dex. The Teffs are selected from Li et al. (2021), spanning [3100,4400] K. The uncertainties in SLAM estimates of [Fe/H] and Teff are ~0.15 dex and ~40 K, respectively, at snri > 100, where snri is the signal-to-noise ratio (SNR) at i-band of M dwarf spectra. We applied the trained SLAM model to determine the [Fe/H] and Teff for ~630,000 M dwarfs with low-resolution spectra in LAMOST DR9. Compared to other literature also using FGK+M wide binaries for calibration, our [Fe/H] estimates show no bias but a scatter of ~ 0.14-0.18 dex. However, the [Fe/H] compared to APOGEE shows a systematic difference of ~ 0.10-0.15 dex with a scatter of ~ 0.15-0.20 dex. While the Teff compared to APOGEE has a bias of 3 K with a scatter of 62 K, it is systematically higher by 180 K compared to other calibrations based on the bolometric temperature. Finally, we calculated the zeta index for 1308 M dwarf secondaries and presents a moderate correlation between zeta and [Fe/H].Comment: 18 pages, 15 Figure

Human MicroRNA Oncogenes and Tumor Suppressors Show Significantly Different Biological Patterns: From Functions to Targets

MicroRNAs (miRNAs) are small noncoding RNAs which play essential roles in many important biological processes. Therefore, their dysfunction is associated with a variety of human diseases, including cancer. Increasing evidence shows that miRNAs can act as oncogenes or tumor suppressors, and although there is great interest in research into these cancer-associated miRNAs, little is known about them. In this study, we performed a comprehensive analysis of putative human miRNA oncogenes and tumor suppressors. We found that miRNA oncogenes and tumor suppressors clearly show different patterns in function, evolutionary rate, expression, chromosome distribution, molecule size, free energy, transcription factors, and targets. For example, miRNA oncogenes are located mainly in the amplified regions in human cancers, whereas miRNA tumor suppressors are located mainly in the deleted regions. miRNA oncogenes tend to cleave target mRNAs more frequently than miRNA tumor suppressors. These results indicate that these two types of cancer-associated miRNAs play different roles in cancer formation and development. Moreover, the patterns identified here can discriminate novel miRNA oncogenes and tumor suppressors with a high degree of accuracy. This study represents the first large-scale bioinformatic analysis of human miRNA oncogenes and tumor suppressors. Our findings provide help for not only understanding of miRNAs in cancer but also for the specific identification of novel miRNAs as miRNA oncogenes and tumor suppressors. In addition, the data presented in this study will be valuable for the study of both miRNAs and cancer

5-Nitro-2-(3-phenylpropylamino) Benzoic Acid Inhibits the Proliferation and Migration of Lens Epithelial Cells by Blocking CaMKII Signaling

Posterior capsule opacification (PCO) is a post-surgery complication of cataract surgery, and lens epithelial cells (LECs) are involved in its development. A suppressive effect on LECs is exerted by the non specific chloride channel inhibitor 5-nitro-2-(3-phenylpropylamino) benzoic acid (NPPB) exerts. Herein, the growth and migration inhibitory effects of NPPB on LECs were assessed, and the mechanism underlying the effects were investigated by focusing on Ca2+/CaMKII signaling. LECs were treated with different concentrations of NPPB, and the changes in cell viability, cell-cycle distribution, anchorage-dependent growth, migration, Ca2+ level, and CaMKII expression were evaluated. NPPB inhibited LECs’ proliferation and induced G1 cell-cycle arrest in the cells. Regarding LECs’ mobility, NPPB suppressed the cells’ anchorage-dependent growth ability and inhibited their migration. Changes in cell phenotypes were associated with an increased intracellular Ca2+ level and down-regulation of CaMKII. Together these results confirmed the inhibitory effect of NPPB on the proliferation and migration of LECs, and the effect was shown to be associated with the induced level of Ca2+ and the inhibition of CaMKII signaling transduction

Influences of beta-alanine and l-histidine supplementation on growth performance, meat quality, carnosine content, and mRNA expression of carnosine-related enzymes in broilers

The current study investigated the effect of dietary L-histidine and beta-alanine sup-plementation on growth performance, meat quality, carnosine content, and gene expression of carnosine-related enzymes in broilers. A two-factor design was adopted in this study. A total of 640 1-day-old male broilers were assigned to eight treatments with factorial arrangement containing four levels of L-histidine (0, 650, 1300, or 1950 mg/kg) and two levels of beta-alanine (0 or 1200 mg/kg) supplementation; 0 mg/kg histidine and/or 0 mg/kg were treated as control groups. Each treatment including eight replicates with 10 birds each and the feeding trial lasted for 42 days. Dietary supple-mentation with L-histidine and beta-alanine did not affect average daily gain (ADG), average daily feed intake (ADFI), and feed conversion ratio (FCR) of broilers during the grower (22–42 days) and the entire phase (1–42 days), compared with the control group (p > 0.05). The only exception was a significantly reduced ADG in the 1950 mg/kg L-histidine group in the starter period (1–21 days, p < 0.05). L-Histidine at 1950 mg/kg significantly decreased redness (a*) and yellowness (b*) values of the meat at 45 min postmortem (p < 0.05), whereas it increased b* value and pH in breast muscle at 24 h postmortem. Moreover, dietary supplementation with beta-alanine alone or combination with L-histidine significantly increased ∆pH in breast muscle (p < 0.01). Dietary L-histidine markedly increased total superoxide dismutase activity and total antioxidant capacity (T-AOC) both in breast muscle (p < 0.01) and in plasma (p < 0.01), and it decreased malondialdehyde (MDA) concentration in breast muscle (p < 0.01). Dietary addition of beta-alanine, alone or combination, significantly increased T-AOC in breast muscle (p < 0.01) and markedly decreased MDA content both in breast muscle and in plasma (p < 0.01). Addition of L-histidine and beta-alanine significantly increased muscle peptide (carnosine and anserine) content (p < 0.05) and upregulated the expression of carno-sine synthase, transporter of carnosine/ L-histidine, and L-histidine decarboxylase genes (p < 0.05), with greater change occurring in the combination group of 1300 mg/kg L-histidine and 1200 mg/kg beta-alanine. Overall, dietary L-histidine and beta-alanine could improve meat quality and antioxi-dant capacity, enhance the carnosine and anserine content, and upregulate the gene expression of carnosine synthesis-related enzymes in broilers

Kinetics of the neutralising antibody response in patients with hand, foot, and mouth disease caused by EV-A71: A longitudinal cohort study in Zhengzhou during 2017-2019

BACKGROUND: Hand, foot, and mouth disease (HFMD) caused by enterovirus A71 (EV-A71) poses a serious threat to children's health. Kinetics of the neutralising antibody (NAb) response in EV-A71 infected HFMD patients remains unclear. The ideal sampling time of paired serum samples for serological diagnosis of EV-A71 infection is not well defined. METHODS: HFMD inpatients admitted to Henan Children's Hospital between February 15, 2017 and February 15, 2018 were enrolled. Serial serum samples collected during hospitalisation and up to 1.5 years after discharge were tested for NAb against EV-A71. Random intercept modelling with B-spline was conducted to characterize the kinetics of the EV-A71 NAb response over time after illness onset. FINDINGS: A total of 524 serum samples from 264 EV-A71 RNA positive HFMD inpatients were collected. NAb titres of EV-A71 infected patients were estimated to increase from 40 (95% CI: 9-180) at the day of onset to the peak of 2417 (95% CI: 1859-3143) at day 13, then remained above 1240 until 26 months. For serological diagnosis of EV-A71 infection, if at least a 4-fold rise in titre was used as the criteria, the acute phase serum should be collected at 0-4 days, the corresponding convalescent serum should be collected 14.9 days (95% CI: 9.1-23.8) after illness onset. INTERPRETATION: EV-A71 infection induced a strong and persistent humoral immune response in HFMD patients. The findings provide a scientific support for determining the collection time of paired serum samples for serological diagnosis of EV-A71 infected HFMD patients. FUNDING: National Science Fund for Distinguished Young Scholar